A-193 A-193 (Loxapine Succinate 25 mg)
Pill with imprint A-193 A-193 is Green / Green, Capsule-shape and has been identified as Loxapine Succinate 25 mg. It is supplied by Actavis Pharma, Inc..
Loxapine is used in the treatment of agitated state; agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A-193 A-193
Loxapine Succinate
- Imprint:
- A-193 A-193
- Strength:
- 25 mg
- Color:
- Green / Green
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 52152-0193
More about loxapine
- Loxapine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 6 Reviews
- Drug class: miscellaneous antipsychotic agents
- FDA Alerts (2)
Consumer resources
- Loxapine
- Loxapine inhalation
- Loxapine Capsules
- Loxapine Inhalation Powder
- Loxapine (Advanced Reading)
- Loxapine Inhalation (Advanced Reading)
Other brands: Loxitane, Adasuve
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
